News
ONVO
--
0.00%
--
GME, AMC, TNXP and NGA among premarket gainers
Pandion Therapeutics (PAND) +132% as Merck to acquire the company for $2.0B.Koss Corporation (KOSS) +92%.Dynatronics Corporation (DYNT) +91% on extension of key distribution agreement.GameStop Corp. (GME) +72%.AmeriServ Financial (ASRV) +33%.Socket Mobile ...
Seekingalpha · 6h ago
Healthcare 3D Printing Market Research Revealing the Growth Rate and Business Opportunities to 2027
Feb 24, 2021 (Heraldkeepers) -- The Global Healthcare 3D Printing Market is expected to exceed more than US$ 5.50 Billion by 2024 at a CAGR of 21.5% in the...
Heraldkeepers · 1d ago
ARK Innovation ETF: Flood of Inflows Creates Liquidity Drought
GuruFocus News · 1d ago
3D Printing Medical Devices Market Revenue, Industry Growing Demand, Size, Share, Business Opportunities, Top Companies, Regional Outlook | By Kenneth Research
Feb 23, 2021 (AmericaNewsHour) -- "Global Spending on Health: A World in Transition", released in theyear 2019 by the World Health Organization (WHO), the...
AmericaNewsHour · 2d ago
Cathie Wood's ARK Invest Posts Fund Sales For Friday, Feb. 19, 2021: VCYT, PACB, TWST, CDNA, ONVO, MTLS, SPLK, HON, BYDDY, AVAV, API
Veracyte (VCYT) - 67,700 Shares Pacific Biosciences (PACB) - 73,715 Twist Bioscience (TWST) - 31,666 CareDx (CDNA) - 105,632 Organovo (ONVO) - 31,711 Materialise (MTLS) - 29,835 Splunk (SPLK) - 82,727 Honeywell
Benzinga · 5d ago
Palantir jumps 15% on big bet from Cathie Wood's Ark Invest. A review of what she bought and sold this week
Ark disclosed its flagship fund — Ark Innovation — bought more than 5.2 million shares of Palantir on Thursday.
CNBC.com · 6d ago
4D Printing Market Size, Share and Analysis Valuation to Cross USD 419.5 million By 2026
Feb 18, 2021 (Market Insight Reports) -- Selbyville, Delaware. The report 4D Printing Market Size and Analysis maintains enhanced dynamics and is...
Market Insight Reports · 02/18 10:47
3D Printing Healthcare Market Global Trends, Market Share, Industry Size, Growth, Opportunities and Market Forecast 2020 to 2027
Market Insight Reports · 02/18 07:47
Cathie Wood’s ARK Investment reveals 20% stake in Organovo
ARK Investment Management, run by the notable fund manager, Catherine Wood has disclosed a ~20.0% stake in Organovo Holdings ([[ONVO]] -3.0%).Per the latest 13F filings, ARK Investment Management holds ~1.42M of
Seekingalpha · 02/17 16:10
Cathie Wood's ARK Invests Posts Fund Sales For Tuesday, Feb. 16, 2021: TWST, PACB, CDNA, VCYT, ONVO, SSYS, MTLS, SPLK, BYDDY, TSM, AVAV, PSTG, PD, Z, API, SE
Twist Bioscience (TWST) - 1,646 Shares Pacific Biosciences (PACB) - 17,049 CareDx (CDNA) - 9,220 Veracyte (VCYT) - 21,481 Organovo (ONVO) - 3,367 Stratasys (SSYS) - 28,069 Materialise (MTLS) - 21,152 Splunk
Benzinga · 02/17 01:07
3D Printing Medical Devices Market 2021- | Opportunity Assessment, Market Challenges, Key vendor Analysis, Share, Growth, Industry Outlook, and Forecast
Feb 16, 2021 (Heraldkeepers) -- The global 3D printing medical devices market is expected to exhibit a robust 18% CAGR over the forecast period from 2018 to...
Heraldkeepers · 02/16 11:22
3D Printing Medical Devices Market Research Report by Manufacturers, Region, Type and Application, Forecast to 2026
Feb 16, 2021 (Heraldkeepers) -- Market Research Engine has published a new report titled as "3D Printing Medical Devices Market Size By Component (Equipment,...
Heraldkeepers · 02/16 10:18
3d Printing Market : Analysis and In-depth Study on Size Trends, Emerging Growth Factors and Regional Forecast | ARC
pune, India, Tue, 16 Feb 2021 00:38:37 / Comserve Inc. / -- The global 3D printing market size is expected to reach around USD 41 Bn by 2026 and will grow at...
Comserve · 02/16 05:40
Global 3D Printing Healthcare Market 2020 Industry Size, Share, In-Depth Qualitative Insights, Growth Opportunity, Regional Analysis by 2025
Feb 15, 2021 (CDN Newswire via Comtex) -- MarketsandResearch.biz has updated its database by adding Global 3D Printing Healthcare Market 2020 by...
CDN Newswire · 02/16 04:53
U.S 3D Bioprinting Industry Market with (Covid-19) Impact Analysis: Worldwide Key Industry Segments & Forecast, 2021-2027
Feb 15, 2021 (Market Insight Reports) -- This report additionally covers the effect of COVID-19 on the worldwide market. The pandemic brought about by...
Market Insight Reports · 02/15 16:25
3D Bioprinting Market Trend Survey 2021 with Top Countries Data Industry Insights by Share, Emerging Trends, Regional Analysis, Segments, Prime Players, Drivers, Growth Factor and Foreseen | With Covid 19 Analysis
Feb 14, 2021 (The Expresswire) -- Global “3D Bioprinting Market” Report 2021 contains a comprehensive analysis of the important segments like market...
The Express Wire · 02/15 03:45
Cathie Wood's Ark Invest was busy in drug stocks this week. A review of what she bought and sold:
Between Monday and Thursday, Ark Innovation bought shares of Novartis and Regeneron Therapeutics.
CNBC.com · 02/13 14:37
Cathie Wood's ARK Invests Posts Fund Sales For Friday, Feb. 12, 2021: ONVO, MTLS, SPCE
Organovo (ONVO) - 4,400 Shares Materialise (MTLS) - 15,003 Virgin Galactic (SPCE) - 255,600
Benzinga · 02/13 00:15
The Daily Biotech Pulse: European Regulatory Nod For Xeris, Amicus Falls On Data, 4 IPOs, FDA Decision For Mallinckrodt's StrataGraft Delayed
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Feb. 12)
Benzinga · 02/12 13:10
3D Printing Medical Devices Market Conditions: Competitors, Clinical Trials, and Pipelines for Diagnostics, Treatments, Cell Therapies And Vaccines During 2021
Feb 11, 2021 (AmericaNewsHour) -- The Global 3D Printing Medical Devices Market was valued at USD 0.68 billion in 2016 and is projected to reach USD 2.82...
AmericaNewsHour · 02/11 13:19
Webull provides a variety of real-time ONVO stock news. You can receive the latest news about Organovo Holdings through multiple platforms. This information may help you make smarter investment decisions.
About ONVO
Organovo Holdings, Inc. is an early commercial-stage company focused on developing and commercializing functional human tissues. The Company focuses on the generation of three-dimensional (3D) human tissues, by utilizing its platform technology to create human tissue constructs in 3D. It is focused on development of products, including 3D human tissues used for the preclinical assessment of drug effects, including applications in predictive toxicology, absorption, distribution, metabolism, excretion (ADME), and drug metabolism and pharmacokinetics (DMPK); customized human tissues as living, dynamic models of human biology or disease, for use in drug discovery and development, and three-dimensional human tissues for clinical applications, such as blood vessels for bypass grafting, nerve grafts for nerve damage repair and functional tissue patches for the repair or replacement of damaged tissues and organs.